Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent GlioblastomaElizabeth R. Gerstner, Tracy T. Batchelor, Ken Chang et al.|Clinical Cancer Research|2019Cited by 64